News

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions ...
Insilico plans late-stage trials for rentosertib following positive mid-stage safety and efficacy data for idiopathic ...
Bosakitug is a Potential Best-in-Class Investigational Monoclonal Antibody with Demonstrated Superior Potency, Residence Time ...